Ten-day concomitant, 10-day sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection: a randomized nationwide trial in Korea

被引：0

作者：

Kim, B. J. ^{[1
]}

Lee, H. ^{[2
]}

Kim, J. ^{[1
,2
]}

机构：

[1] Chung Ang Univ Hosp, Seoul, South Korea

[2] Sungkyunkwan Univ, Coll Med, Seoul, South Korea

来源：

HELICOBACTER | 2019年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

W5.3

引用

页数：2

共 50 条

[31] Economic analysis and outcomes of 10-day sequential therapy compared to 10-day triple therapy for Helicobacter pylori (H pylori) eradication
Vakil, Nimish
Zullo, Angelo
Ricci, Chiara
Vaira, Dino
GASTROENTEROLOGY, 2008, 134 (04) : A619 - A619
[32] A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL OF VONOPRAZAN VERSUS PPI BASED 7-DAY TRIPLE THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION
Sue, Soichiro
Kuwashima, Hirohumi
Arima, Isao
Ogushi, Marina
Nakao, Satoshi
Naito, Makoto
Komatu, Kazuto
Yamada, Hiroaki
Kaneko, Hiroaki
Tamura, Toshihide
Sasaki, Tomohiko
Kondo, Masaaki
Shibata, Wataru
Maeda, Shin
GASTROENTEROLOGY, 2017, 152 (05) : S250 - S250
[33] Ten-day sequential versus triple therapy for Helicobacter pylori eradication: A prospective, open-label, randomized trial
Chung, Jun-Won
Jung, Young Kul
Kim, Yoon Jae
Kwon, Kwang Ahn
Kim, Jung Ho
Lee, Jong Joon
Lee, Sung Min
Hahm, Ki Baik
Lee, Sun Mi
Jeong, Jin Yong
Yun, Sung-Cheol
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (11) : 1675 - 1680
[34] Helicobacter pylori eradication with either seven-day or 10-day triple therapies, and with a 10-day sequential regimen
Scaccianoce, G
Hassan, C
Panarese, A
Piglionica, D
Morini, S
Zullo, A
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (02) : 113 - 117
[35] HELICOBACTER PYLORI ERADICATION RATES WITH 10-DAY NON-BISMUTH QUADRUPLE THERAPY AND 10-DAY SEQUENTIAL THERAPY IN KOREA
Kim, S. Y.
Lee, J.
Chung, S. Y.
Jung, S. W.
Park, J. J.
Chun, H. J.
Lee, S. W.
HELICOBACTER, 2014, 19 : 131 - 131
[36] 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
Greenberg, E. Robert
Anderson, Garnet L.
Morgan, Douglas R.
Torres, Javier
Chey, William D.
Eduardo Bravo, Luis
Dominguez, Ricardo L.
Ferreccio, Catterina
Herrero, Rolando
Lazcano-Ponce, Eduardo C.
Mercedes Meza-Montenegro, Maria
Pena, Rodolfo
Pena, Edgar M.
Salazar-Martinez, Eduardo
Correa, Pelayo
Elena Martinez, Maria
Valdivieso, Manuel
Goodman, Gary E.
Crowley, John J.
Baker, Laurence H.
LANCET, 2011, 378 (9790): : 507 - 514
[37] A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication
Heo, Jun
Jeon, Seong Woo
Jung, Jin Tae
Kwon, Joong Goo
Kim, Eun Young
Lee, Dong Wook
Seo, Hyang Eun
Ha, Chang Yoon
Kim, Hyun Jin
Kim, Eun Soo
Park, Kyung Sik
Cho, Kwang Bum
Lee, Si Hyung
Jang, Byung Ik
DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) : 980 - 984
[38] Randomized clinical trial comparing 10-or 14-day sequential therapy and 10-or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection
Kim, J.
Kim, B.
HELICOBACTER, 2017, 22
[39] TEN-DAY SEQUENTIAL THERAPY IS A PROMISING THERAPEUTIC APPROACH FOR HELICOBACTER PYLORI INFECTION IN NAIVE PATIENTS: A RANDOMIZED MULTICENTER TRIAL
Kim, S.
Park, H.
Jung, M.
Huh, J.
Jeon, S.
HELICOBACTER, 2012, 17 : 99 - 100
[40] Randomized clinical trial comparing 10-or 14-day sequential therapy and 10-or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection
Park, Sung Min
Kim, Joon Sung
Kim, Byung-Wook
Ji, Jeong-Seon
Choi, Hwang
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 589 - 594

← 1 2 3 4 5 →